vimarsana.com

VYNE Therapeutics (NASDAQ:VYNE – Get Rating) had its price target lifted by Cantor Fitzgerald from $5.00 to $9.00 in a report released on Friday morning, The Fly reports. Separately, HC Wainwright reaffirmed a buy rating and set a $28.00 target price on shares of VYNE Therapeutics in a report on Wednesday, April 19th. VYNE Therapeutics […]

Related Keywords

Patrickg Lepore , ,Molecule Stabilizing Technology ,Beacon Pointe Advisors ,Mackenzie Financial Corp ,Cetera Advisor Networks ,Therapeutics Inc ,Millennium Management ,Cantor Fitzgerald ,Therapeutics Company Profile ,Get Rating ,Director Patrick ,Financial Corp ,Advisor Networks ,Pointe Advisors ,Molecule Stabilizing ,Vyne Therapeutics ,Nasdaq Vyne ,Vyne ,Medical ,Boost Price Target ,

© 2025 Vimarsana

vimarsana.com © 2020. All Rights Reserved.